Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.39 |
| ▸ | AKR1C3 | P42330 | 7/20 | 0.35 |
| ▸ | SYK | P43405 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.33 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12110790 | 0.93 | THRB (0.40) | THRBAKR1C3AKR1C2ADRB2ADRB1 | |
| SCHEMBL14185457 | 0.91 | THRB (0.39) | THRBAKR1C3SYKAKR1C2ADRB2 | |
| SCHEMBL14088569 | 0.90 | THRB (0.40) | THRBAKR1C3PPARGPPARDPPARA | |
| SCHEMBL13560674 | 0.90 | THRB (0.46) | THRBAKR1C3AKR1C2ADRB2ADRB1 | |
| SCHEMBL14088570 | 0.89 | THRB (0.40) | THRBAKR1C3PPARGPPARDPPARA | |
| SCHEMBL12567642 | 0.85 | THRB (0.34) | THRBADRB2ADRB1 | |
| SCHEMBL12154229 | 0.83 | THRB (0.42) | THRBAKR1C3AKR1C2PPARGFFAR1 | |
| SCHEMBL14588364 | 0.82 | THRB (0.44) | THRBAKR1C3PPARGPPARAFFAR1 | |
| SCHEMBL14088407 | 0.82 | THRB (0.43) | THRBAKR1C3PPARGFFAR1 | |
| SCHEMBL5961815 | 0.82 | THRB (0.33) | THRBADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9541690-B2 | Film using polymerizable liquid crystal composition containing peeling preventive agent | JNC CORPORATION (JP) | 2017-01-10 | — | — | US | disclosed |
| US-20140308462-A1 | FILM USING POLYMERIZABLE LIQUID CRYSTAL COMPOSITION CONTAINING PEELING PREVENTIVE AGENT | JNC PETROCHEMICAL CORPORATION (JP) | 2014-10-16 | — | — | US | disclosed |
| US-20140049738-A1 | THREE-DIMENSIONAL IMAGE DISPLAY APPARATUS | JNC PETROCHEMICAL CORPORATION (JP) | 2014-02-20 | — | — | US | disclosed |
| US-8425988-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition and anisotropic polymer | JNC CORPORATION (JP) | 2013-04-23 | — | — | US | disclosed |
| US-20110147657-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND ANISOTROPIC POLYMER | CHISSO CORPORATION (JP) | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110147657-A1 | POLYMERIZABLE LIQUID CRYSTAL COMPOUND, POLYMERIZABLE LIQUID CRYSTAL COMPOSITION AND ANISOTROPIC POLYMER | SSB, LEF1, UACA | THRB 4550/4885AKR1C3 1983/4885SYK 192/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.